Female Sexual Dysfunction Clinical Trials

6 recruitingLast updated: July 25, 2026

There are 6 actively recruiting female sexual dysfunction clinical trials across 4 countries. Studies span Not Applicable, Phase 2. Top locations include Banī Suwayf, Egypt, Ann Arbor, Michigan, United States, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Female Sexual Dysfunction Trials at a Glance

6 actively recruiting trials for female sexual dysfunction are listed on ClinicalTrialsFinder across 5 cities in 4 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Banī Suwayf, Ann Arbor, and Bethesda. Lead sponsors running female sexual dysfunction studies include Benha University, Beni-Suef University, and Biozeus Biopharmaceutical S.A..

Browse female sexual dysfunction trials by phase

About Female Sexual Dysfunction Clinical Trials

Looking for clinical trials for Female Sexual Dysfunction? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Female Sexual Dysfunction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Female Sexual Dysfunction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

Assessment of Female Sexual Function Index (FSFI) Scores at 1 Month After Endometrial Sampling Performed Under Sedo-Analgesia or Local Anesthesia

Female Sexual DysfunctionEndometrial SamplingFemale Sexual Function Index (FSFI)+1 more
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization210 enrolled1 locationNCT07628660
Recruiting
Not Applicable

Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Cervical CancerFemale Sexual Dysfunction (FSD)Radiation Induced Pelvic Floor Muscle Dysfunction
Beni-Suef University60 enrolled1 locationNCT07597083
Recruiting
Not Applicable

Effects of Extracorporeal Shockwave Therapy Versus Pulsed Electromagnetic Field Therapy in Females With Sexual Dysfunction.

Pelvic Floor Muscle TrainingShock WaveFemale Sexual Dysfunction (FSD)+1 more
Benha University90 enrolled1 locationNCT07584174
Recruiting
Not Applicable

At-Home Neuromodulation for Female Sexual Dysfunction

Female Sexual Dysfunction
University of Michigan24 enrolled1 locationNCT06932302
Recruiting

Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome

Female Sexual DysfunctionBladder Pain Syndrome
Walter Reed National Military Medical Center159 enrolled1 locationNCT06729151
Recruiting
Phase 2

Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder

Female Sexual DysfunctionFemale Sexual Arousal Disorder
Biozeus Biopharmaceutical S.A.30 enrolled1 locationNCT06116045